Nippon Life Global Investors Americas, Inc. Amgen Inc Transaction History

Nippon Life Global Investors Americas, Inc.

$2.22 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $7.78 Million - $8.65 Million	-33,710 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $368,373 - $407,517	1,680 Added 5.25%	33,710 $8.15 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $795,520 - $910,400	4,000 Added 14.27%	32,030 $7.21 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $477,607 - $559,575	-2,250 Reduced 7.43%	28,030 $5.96 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $474,887 - $553,404	-2,140 Reduced 6.6%	30,280 $7.53 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $7.02 Million - $8.35 Million	32,420 New	32,420 $7.45 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $11.2 Million - $12.5 Million	-66,330 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $11.1 Million - $12.7 Million	66,330	66,330 $12.4 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account